课题基金 / 基金详情

Clinical Research Products Development Center (CRPMC)

Clinical Research Products Development Center (CRPMC)
临床研究产品开发中心(CRPMC)
批准号:
10197287
负责人:
NEERAJA PUTTA
金额:
$757.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-16 至 2021-06-15

项目摘要

项目成果

NEERAJA PUTTA的其他基金

相似基金

相关文献

中文摘要
翻译
NIAID艾滋病司(DAIDS)要求管理和运营一个临床研究产品管理中心(CRPMC),以支持NIAID赞助的国内和国际临床研究试验,其核心重点是艾滋病毒/艾滋病及其合并症。该合同将通过提供符合cGMP的设施、接收、储存、标签、包装、重新包装、运输、获取和处置研究产品来提供药物服务和研究产品管理。该合同将提供认知制药服务,包括评估协议草案;审查现场药房监测报告并维护现场审计药房报告数据库;向临床现场药剂师提供研究产品储存和稳定性信息、研究药房实践和研究产品管理活动方面的指导;以及对生产设施进行当前的良好制造规范(CGMP)审计。
英文摘要
NIAID Division of AIDS (DAIDS) has a requirement for the management and operation of a Clinical Research Products Management Center (CRPMC) to support NIAID-sponsored clinical research trials both domestically and internationally, with a core focus of HIV/AIDS and its co-morbidities. This contract will provide pharmaceutical services and study product management by providing a cGMP-compliant facility, receipt, storage, labeling, packaging, repackaging, shipping, acquiring, and disposition of study products. This contract will provide cognitive pharmaceutical services including evaluating draft protocols; reviewing site pharmacy monitoring reports and maintaining a site audit pharmacy report database; providing study product storage and stability information, guidance in research pharmacy practice and study product management activities to clinical site pharmacists; and conducting Current Good Manufacturing Practice (cGMP) audits of manufacturing facilities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19: Clinical Research Products Development Center (CRPMC)
  • 批准号:
    10244841
  • 项目类别:
  • 资助金额:
    $119.67万
  • 财政年份:
    2020
  • 负责人:
    NEERAJA PUTTA
  • 依托单位:
海外基金